Á lódáil...
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome
OBJECTIVE: Extreme obesity is a core phenotypic feature of Prader–Willi syndrome (PWS). Among numerous metabolic regulators, the endocannabinoid (eCB) system is critically involved in controlling feeding, body weight, and energy metabolism, and a globally acting cannabinoid-1 receptor (CB(1)R) block...
Na minha lista:
| Foilsithe in: | Mol Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Elsevier
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5123200/ https://ncbi.nlm.nih.gov/pubmed/27900261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2016.10.004 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|